Ken Griffin Connect Biopharma Holdings LTD Transaction History
Citadel Advisors LLC
- $559 Billion
- Q4 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Connect Biopharma Holdings LTD stock. As of the latest transaction made, Citadel Advisors LLC holds 14,000 shares of CNTB stock, worth $11,620. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,000Holding current value
$11,620% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding CNTB
# of Institutions
17Shares Held
3.28MCall Options Held
14KPut Options Held
0-
Bml Capital Management, LLC Zionsville, IN2.09MShares$1.74 Million1.79% of portfolio
-
Ubs Oconnor LLC Chicago, IL511KShares$423,8810.04% of portfolio
-
Choreo, LLC Minneapolis, MN161KShares$133,5190.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny135KShares$111,7980.0% of portfolio
-
Black Rock Inc. New York, NY104KShares$86,2290.0% of portfolio
About Connect Biopharma Holdings Ltd
- Ticker CNTB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,015,800
- Market Cap $45.7M
- Description
- Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...